https://www.tipranks.com/news/the-fly/enphase-energy-price-target-lowered-to-90-from-100-at-roth-mkm Cantor Fitzgerald raised the firm’s price target on Atlassian ...

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...

On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on Cipher Mining shares (NASDAQ:CIFR), with a set price target of $11.00. The firm's analyst, Brett Knoblauch, provided insight into ...

Cantor Fitzgerald analyst C.J. Muse lowered the firm’s price target on Teradyne (TER) to $150 from $160 and keeps an Overweight rating on the shares. Teradyne reported another disappointing ...

Acrivon Therapeutics, Inc. (ACRV – Research Report) received a Buy rating and price target from Cantor Fitzgerald analyst Li Watsek today. The company’s shares closed yesterday at $5.79.

Cantor Fitzgerald initiated coverage of Acrivon Therapeutics (ACRV) with an Overweight rating without a price target The company has two clinical assets and a next-generation precision medicine ...

In a report released yesterday, C J Muse from Cantor Fitzgerald maintained a Hold rating on KLA (KLAC – Research Report), with a price target of $875.00. The company’s shares closed yesterday ...

In a report released yesterday, Brett Knoblauch from Cantor Fitzgerald maintained a Buy rating on Cipher Mining (CIFR – Research Report), with a price target of $11.00. The company’s shares ...

Cantor Fitzgerald analyst C J Muse maintained a Hold rating on Intel (INTC – Research Report) yesterday and set a price target of $22.00. The company’s shares closed yesterday at $20.01.

Cantor Fitzgerald analyst Thomas Blakey reiterated a Hold rating on Atlassian (TEAM – Research Report) yesterday and set a price target of $304.00. The company’s shares closed yesterday at ...

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer yesterday. The company’s shares closed yesterday ...

Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (WBAG:LRC2) from Neutral to Overweight. There are 1,883 funds or institutions reporting positions ...